Horizon Kinetics Medical ETF (MEDX)
| Assets | $19.27M |
| Expense Ratio | 0.85% |
| PE Ratio | 21.21 |
| Shares Out | 569,946 |
| Dividend (ttm) | $0.50 |
| Dividend Yield | 1.49% |
| Ex-Dividend Date | Dec 24, 2024 |
| Payout Ratio | 31.61% |
| 1-Year Return | +18.13% |
| Volume | 843 |
| Open | 33.44 |
| Previous Close | 33.71 |
| Day's Range | 33.42 - 33.52 |
| 52-Week Low | 23.46 |
| 52-Week High | 34.10 |
| Beta | 0.58 |
| Holdings | 35 |
| Inception Date | Jan 27, 2023 |
About MEDX
Fund Home PageThe Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is issued by Horizon Kinetics.
Top 10 Holdings
70.60% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 17.72% |
| AbbVie Inc. | ABBV | 8.69% |
| US BANK MMDA - USBGFS 7 | n/a | 8.56% |
| Novartis AG ADR | NVSN.MX | 6.40% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 5.82% |
| AstraZeneca PLC | AZN | 5.22% |
| Ionis Pharmaceuticals, Inc. | IONS | 5.12% |
| Johnson & Johnson | JNJ | 4.98% |
| Bristol-Myers Squibb Company | BMY | 4.08% |
| Amgen Inc. | AMGN | 4.03% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 24, 2024 | $0.50233 | Dec 26, 2024 |
| Dec 27, 2023 | $2.88017 | Dec 29, 2023 |
News
3 Value Picks From the Oakmark International Small Cap Fund
The Oakmark Intl Small Cap (Trades, Portfolio) Fund recently disclosed its portfolio updates on its website for the fiscal quarter ended March 31. The company's fiscal year ends on Sept.
Horizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)
NEW YORK, NY / ACCESSWIRE / January 30, 2023 / Horizon Kinetics LLC today launched the Horizon Kinetics SPAC Active ETF (NASDAQ:SPAQ) and the Horizon Kinetics Medical ETF (NASDAQ:MEDX). SPAQ was conve...